Editas Medicine Announces First Quarter 2019 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Editas Medicine (EDIT) Reports Q1 Loss of $0.60
May 7, 2019 4:38 PM EDTEditas Medicine (NASDAQ: EDIT) reported Q1 EPS of ($0.60), versus $0.67 reported last year. Revenue for the quarter came in at $2.07 million, versus $3.93 million reported last year.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More